LONDON (Reuters) - The global pharmaceutical industry is tightening its code of practice in a bid to stamp out bribery and corruption, particularly in emerging markets.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/FfXyPtb8J0M/us-global-drug-industry-idUSTRE82029G20120301
top news recent news save money travel make money best news
No comments:
Post a Comment